Literature DB >> 23649437

Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Alessandro Brunelli1, Anthony W Kim2, Kenneth I Berger3, Doreen J Addrizzo-Harris4.   

Abstract

BACKGROUND: This section of the guidelines is intended to provide an evidence-based approach to the preoperative physiologic assessment of a patient being considered for surgical resection of lung cancer.
METHODS: The current guidelines and medical literature applicable to this issue were identified by computerized search and were evaluated using standardized methods. Recommendations were framed using the approach described by the Guidelines Oversight Committee.
RESULTS: The preoperative physiologic assessment should begin with a cardiovascular evaluation and spirometry to measure the FEV1 and the diffusing capacity for carbon monoxide (Dlco). Predicted postoperative (PPO) lung functions should be calculated. If the % PPO FEV1 and % PPO Dlco values are both > 60%, the patient is considered at low risk of anatomic lung resection, and no further tests are indicated. If either the % PPO FEV1 or % PPO Dlco are within 60% and 30% predicted, a low technology exercise test should be performed as a screening test. If performance on the low technology exercise test is satisfactory (stair climbing altitude > 22 m or shuttle walk distance > 400 m), patients are regarded as at low risk of anatomic resection. A cardiopulmonary exercise test is indicated when the PPO FEV1 or PPO Dlco (or both) are < 30% or when the performance of the stair-climbing test or the shuttle walk test is not satisfactory. A peak oxygen consumption (V˙O2 peak) < 10 mL/kg/min or 35% predicted indicates a high risk of mortality and long-term disability for major anatomic resection. Conversely, a V˙O2 peak > 20 mL/kg/min or 75% predicted indicates a low risk.
CONCLUSIONS: A careful preoperative physiologic assessment is useful for identifying those patients at increased risk with standard lung cancer resection and for enabling an informed decision by the patient about the appropriate therapeutic approach to treating his or her lung cancer. This preoperative risk assessment must be placed in the context that surgery for early-stage lung cancer is the most effective currently available treatment of this disease.

Entities:  

Mesh:

Year:  2013        PMID: 23649437     DOI: 10.1378/chest.12-2395

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  171 in total

Review 1.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

2.  Worse Prognosis for Stage IA Lung Cancer Patients with Smoking History and More Severe Chronic Obstructive Pulmonary Disease.

Authors:  Yukihiro Yoshida; Hidenori Kage; Tomohiro Murakawa; Yasunori Sato; Satoshi Ota; Masashi Fukayama; Jun Nakajima
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-01-26       Impact factor: 1.520

3.  Early postoperative inflammatory response by procedure types: stapler-based segmentectomy versus lobectomy.

Authors:  Yuya Ishikawa; Fumitsugu Kojima; Taisuke Ishii; Nobuyuki Yoshiyasu; Sachiko Ohde; Toru Bando
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-09-26

4.  Impact of Sublobar Resection on Pulmonary Function: Long-Term Results from American College of Surgeons Oncology Group Z4032 (Alliance).

Authors:  Michael S Kent; Sumithra J Mandrekar; Rodney Landreneau; Francis Nichols; Thomas A DiPetrillo; Bryan Meyers; Dwight E Heron; David R Jones; Angelina D Tan; Sandra Starnes; Joe B Putnam; Hiran C Fernando
Journal:  Ann Thorac Surg       Date:  2016-04-19       Impact factor: 4.330

5.  Feasibility analysis for the development of a video-assisted thoracoscopic (VATS) lobectomy 23-hour recovery pathway.

Authors:  Teodora-Cristiana Dumitra; Juan-Carlos Molina; Jack Mouhanna; Ioana Nicolau; Stephane Renaud; Ludovic Aubin; Aya Siblini; David Mulder; Lorenzo Ferri; Jonathan Spicer
Journal:  Can J Surg       Date:  2020-07-31       Impact factor: 2.089

6.  Major morbidity after video-assisted thoracic surgery lung resections: a comparison between the European Society of Thoracic Surgeons definition and the Thoracic Morbidity and Mortality system.

Authors:  Alberto Sandri; Kostas Papagiannopoulos; Richard Milton; Emmanuel Kefaloyannis; Nilanjan Chaudhuri; Emily Poyser; Nicholas Spencer; Alessandro Brunelli
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

7.  Outcome of patients with lung cancer and severe psychiatric disorder admitted to a medical psychiatric unit.

Authors:  Tomohiro Takehara; Tetsuo Tani; Hiroyuki Takiue; Ryo Takeshita; Arifumi Iwamaru; Tatsuya Yamamoto; Hidefumi Koh
Journal:  Mol Clin Oncol       Date:  2020-01-10

8.  Heart rate variability and heart rate recovery in lung cancer survivors eligible for long-term cure.

Authors:  Duc Ha; Atul Malhotra; Andrew L Ries; Wesley T O'Neal; Mark M Fuster
Journal:  Respir Physiol Neurobiol       Date:  2019-07-31       Impact factor: 1.931

9.  Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a word of caution.

Authors:  Gonzalo Varela; María Teresa Gómez-Hernández
Journal:  Transl Lung Cancer Res       Date:  2016-02

Review 10.  Preoperative Evaluation and Indications for Pulmonary Metastasectomy.

Authors:  Loretta Erhunmwunsee; Betty C Tong
Journal:  Thorac Surg Clin       Date:  2016-02       Impact factor: 1.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.